<PAGE>
U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q/A
___________________________________________
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (D) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 1998
or
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the transition period from __________________ to _______________
Commission file number: 0-24260
--------
AMEDISYS, INC.
--------------
(Exact Name of Registrant as Specified in Charter)
Delaware 11-3131700
-------- ----------
(State or Other Jurisdiction of (I.R.S. Employer
Incorporation or Organization) Identification No.)
3029 S. Sherwood Forest Blvd., Ste. 300 Baton Rouge, LA 70816
---------------------------------------------------------------
(Address of principal executive offices including zip code)
(504) 292-2031
--------------
(Registrant's telephone number, including area code)
Indicate by check mark whether the issuer (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days. Yes [X] No [ ]
Number of shares of Common Stock outstanding as of June 30, 1998: 3,064,918
shares
1
<PAGE>
PART I.
FINANCIAL INFORMATION
---------------------
ITEM 1. FINANCIAL STATEMENTS
Consolidated Balance Sheets as of June 30, 1998 and December 31, 1997... 3
Consolidated Statements of Operations for the Three and Six Months
ended June 30, 1998 and 1997....................................... 4
Consolidated Statements of Cash Flows for the Six Months ended
June 30, 1998 and 1997............................................. 5
Notes to Consolidated Financial Statements.............................. 6
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS...............................................11
PART II.
OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS..................................................13
ITEM 2. CHANGES IN SECURITIES..............................................13
ITEM 3. DEFAULTS UPON SENIOR SECURITIES....................................13
ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS................14
ITEM 5. OTHER INFORMATION..................................................14
ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K...................................14
2
<PAGE>
AMEDISYS, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEET
AS OF JUNE 30, 1998 AND DECEMBER 31, 1997
(UNAUDITED, IN 000'S)
ASSETS JUNE 30, DECEMBER 31,
1998 1997
CURRENT ASSETS:
Cash $ 471 $ 4,070
Accounts Receivable, Net of Allowance for Doubtful
Accounts of $2,957 in June 1998 and $1,617 in
December 1997 4,292 9,630
Prepaid Expenses 891 247
Other Current Assets 4,004 654
------- ------
Total Current Assets 9,658 14,601
Notes Receivable from Related Parties 224 252
Property, Plant and Equipment, Net 6,056 4,785
Other Assets, Net 12,374 3,232
------- ------
Total Assets $ 28,312 $ 22,870
======= ======
LIABILITIES
CURRENT LIABILITIES:
Notes Payable $ 6,090 $ 5,806
Current Portion of Long-Term Debt 927 927
Accounts Payable 2,486 1,338
Accrued Expenses:
Payroll and Payroll Taxes 1,541 2,025
Insurance 1,020 521
Other 1,398 847
------- ------
Total Current Liabilities 13,462 11,464
Long-Term Debt 4,948 3,129
Other Long-Term Liabilities 1,136 0
------- ------
Total Liabilities 19,546 14,593
------- ------
Minority Interest 3 3
------- ------
STOCKHOLDERS' EQUITY
Common Stock 3 3
Preferred Stock 1 1
Additional paid-in capital 12,006 7,092
Treasury Stock (25) (25)
Stock Subscriptions Receivable (1) 0
Retained Earnings (deficit) (3,221) 1,203
------- ------
Total Stockholders' Equity 8,763 8,274
------- ------
Total Liabilities and Stockholders' Equity $ 28,312 $ 22,870
======= ======
SEE ACCOMPANYING NOTES TO FINANCIAL STATEMENTS.
3
<PAGE>
Amedisys, Inc. and Subsidiaries
CONSOLIDATED STATEMENTS OF OPERATIONS
for the three and six months ended June 30, 1998 and 1997
(Unaudited, in 000's except per share data)
<TABLE>
<CAPTION>
THREE MONTHS ENDED SIX MONTHS ENDED
--------------------- ------------------
JUNE 98 JUNE 97 JUNE 98 JUNE 97
<S> <C> <C> <C> <C>
Income:
Service revenue $ 11,765 $ 13,880 $ 24,475 $ 27,264
Cost of service revenue 6,652 8,094 14,319 15,973
------- ------- ------- -------
Gross margin 5,113 5,786 10,156 11,291
------- ------- ------- -------
General and administrative expenses:
Salaries and benefits 4,151 2,763 9,389 5,497
Other 3,663 2,276 7,098 4,433
------- ------- ------- -------
Total general and administrative expenses 7,814 5,039 16,487 9,930
------- ------- ------- -------
Operating income (loss) (2,701) 747 (6,331) 1,361
------- ------- ------- -------
Other income and expense:
Interest income 9 15 21 18
Interest expense (215) (209) (418) (393)
Miscellaneous 17 58 25 76
------- ------- ------- -------
Total other income and expenses (189) (136) (372) (299)
------- ------- ------- -------
Income (loss) before income taxes and minority interest (2,890) 611 (6,703) 1,062
Provision (benefit) for estimated income taxes (987) 217 (2,279) 379
------- ------- ------- -------
Income (loss) before minority interest (1,903) 394 (4,424) 683
Minority interest in consolidated subsidiary 0 (21) 0 (9)
------- ------- ------- -------
Net income (loss) $ (1,903) $ 373 $ (4,424) $ 674
======= ======= ======= =======
Basic earnings (losses) per common share $ (0.62) $ 0.14 $ (1.45) $ 0.26
======= ======= ======= =======
Weighted average common shares outstanding 3,064 2,697 3,057 2,639
======= ======= ======= =======
</TABLE>
SEE ACCOMPANYING NOTES TO FINANCIAL STATEMENTS.
4
<PAGE>
AMEDISYS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE SIX MONTHS ENDED JUNE 30, 1998 AND 1997
(UNAUDITED, IN 000'S)
<TABLE>
<CAPTION>
JUNE 1998 JUNE 1997
<S> <C> <C>
CASH FLOWS FROM OPERATING ACTIVITIES:
NET INCOME (LOSS) $ (4,424) $ 674
ADJUSTMENTS TO RECONCILE NET INCOME TO NET
CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES:
DEPRECIATION AND AMORTIZATION 870 581
PROVISION FOR BAD DEBTS 415 425
MINORITY INTEREST IN AFFILIATED COMPANY 0 9
(GAIN) LOSS ON DISPOSAL OF PROPERTY AND EQUIPMENT 4 (13)
LOSS ON SALE OF MARKETABLE SECURITIES 0 3
CHANGES IN ASSETS AND LIABILTIES:
(INCREASE) DECREASE IN ACCOUNTS RECEIVABLE 3,919 (974)
(INCREASE) IN PREPAID EXPENSES (644) (189)
(INCREASE) IN OTHER CURRENT ASSETS (3,217) (3)
(INCREASE) IN OTHER ASSETS (198) (391)
INCREASE (DECREASE) IN ACCOUNTS PAYABLE 170 (603)
INCREASE (DECREASE) IN ACCRUED EXPENSES (515) 723
--------- --------
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES (3,620) 242
--------- --------
CASH FLOW FROM INVESTING ACTIVITIES:
PURCHASE OF FURNITURE, FIXTURES & EQUIPMENT (1,625) (754)
PROCEEDS FROM SALE OF FURNITURE, FIXTURES & EQUIPMENT 0 56
CASH PAID FOR ACQUISITIONS (2,005) 0
(INCREASE) DECREASE IN NOTES RECEIVABLE FROM RELATED PARTIES 28 (5)
--------- --------
NET CASH (USED IN) INVESTING ACTIVITIES (3,602) (703)
--------- --------
CASH FLOW FROM FINANCING ACTIVITIES:
PURCHASE OF TREASURY STOCK 0 (25)
CASH RECEIVED IN ACQUISITIONS 317 0
NET INCREASE IN BORROWINGS ON LINE OF CREDIT 284 672
PAYMENTS ON NOTES PAYABLE (704) (377)
PROCEEDS FROM NOTES PAYABLE 473 1,704
INCREASE (DECREASE) IN NOTES PAYABLE TO RELATED PARTIES 0 (988)
PROCEEDS FROM COMMON STOCK 0 831
DECREASE IN STOCK SUBSCRIPTIONS 0 1
PROCEEDS FROM PREFERRED STOCK 3,253 0
--------- --------
NET CASH PROVIDED BY FINANCING ACTIVITIES 3,623 1,818
--------- --------
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS (3,599) 1,357
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD 4,070 1,104
--------- --------
CASH AND CASH EQUIVALENTS AT END OF PERIOD $ 471 $ 2,461
========= ========
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
CASH PAYMENTS FOR:
INTEREST $ 426 $ 360
========= ========
INCOME TAXES $ 151 $ 22
========= ========
SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING ACTIVITY (SEE NOTE 9 TO FINANCIAL STATEMENTS):
VALUE OF STOCK ISSUED IN EXCHANGE $ 894
VALUE OF NOTE PAYABLE ISSUED IN EXCHANGE 1,575
CASH ACQUIRED IN EXCHANGE (317)
WORKING CAPITAL DEFICIT ACQUIRED NET OF CASH AND CASH EQUIVALENTS 3,553
FAIR VALUE OF PROPERTY, PLANT AND EQUIPMENT ACQUIRED (385)
FAIR VALUE OF OTHER ASSETS ACQUIRED (27)
LONG TERM DEBT ASSUMED 3,069
FAIR VALUE OF OTHER LIABILTIES ASSUMED 54
---------
NON CASH PORTION OF ACQUISITIONS 8,416
CASH PAYMENT FOR ACQUISITIONS 2,005
---------
GOODWILL RECORDED IN EXCHANGE $ 10,421
=========
</TABLE>
SEE ACCOMPANYING NOTES TO FINANCIAL STATEMENTS.
5
<PAGE>
AMEDISYS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
1. UNAUDITED FINANCIAL INFORMATION
The financial information as of June 30, 1998 and 1997, included herein is
unaudited; however, such information reflects, in the opinion of management, all
adjustments (consisting solely of normal recurring adjustments) that are
necessary to present fairly the results of operations for such periods. Results
of operations for the interim periods are not necessarily indicative of results
of operations which will be realized for the year ending December 31, 1998.
These interim consolidated financial statements should be read in conjunction
with the Company's annual financial statements and related notes in the
Company's Form 10-K.
2. EARNINGS PER SHARE
In February 1997, the Financial Accounting Standards Board (FASB) issued
Statement of Financial Accounting Standards (SFAS) No. 128, "Earnings Per
Share," which simplifies the computation of earnings per share (EPS). The
Company adopted SFAS No. 128 in the fourth quarter of 1997. SFAS No. 128
requires the restatement of prior years' EPS data; however, application of the
statement has no impact on the Company's prior years' EPS data.
Basic net income per share of common stock is calculated by dividing net
income applicable to common stock by the weighted-average number of common
shares outstanding during the year. Diluted net income per share is not
presented as stock options and convertible securities outstanding during the
periods presented were not dilutive.
3. RECENT ACCOUNTING PRONOUNCEMENTS
Accounting for Start-up Costs. During April 1998, the Accounting Standards
Executive Committee of the AICPA issued Statement of Position 98-5 ("SOP"),
"Reporting on the Costs of Start-Up Activities." The SOP requires costs of
start-up activities and organization costs to be expensed as incurred. The SOP
is effective for financial statements for fiscal years beginning after December
15, 1998. The Company elected to write off start-up costs in the fourth quarter
of 1997 in anticipation of the issuance of the SOP.
Accounting for Derivative Instruments and Hedging Activities. In June
1998, the Financial Accounting Standards Board issued Statement of Financial
Accounting Standards No. 133 ("SFAS 133"), "Accounting for Derivative
Instruments and Hedging Activities". The Statement establishes accounting and
reporting standards requiring that every derivative instrument (including
certain derivative instruments embedded in other contracts) be recorded in the
balance sheet as either an asset or liability measured at its fair value. The
Statement requires that changes in the derivative's fair value be recognized
currently in earnings unless specific hedge accounting criteria are met.
Special accounting for qualifying hedges allows a derivative's gains and losses
to offset related results on the hedged item in the income statement, and
requires that a company must formally document, designate, and assess the
effectiveness of transactions that receive hedge accounting. SFAS 133 is
effective for fiscal years beginning after June 15, 1999 and must be applied to
instruments issued, acquired, or substantively modified after December 31, 1997.
The Company does not expect the adoption of the accounting pronouncement to have
a material effect on its financial position or results of operations.
4. MEDICARE REIMBURSEMENT REDUCTIONS AND RELATED RESTRUCTURING
The Company derives approximately 40% of its revenues from the Medicare
system. In 1997, Congress approved the Balanced Budget Act of 1997 (the "Budget
Act"). The Budget Act established an interim payment system (the "IPS") that
provided for the lowering of reimbursement limits for home health visits. For
cost reporting periods beginning on or after October 1, 1997, Medicare-
reimbursed home health agencies will have their cost
6
<PAGE>
limits determined as the lesser of (i) their actual costs, (ii) cost limits
based on 105% of median costs of freestanding home health agencies, or (iii) an
agency-specific per-patient cost limit, based on 98% of 1994 costs adjusted for
inflation. The new IPS cost limits will apply to the Company for the cost
reporting period beginning January 1, 1998. On March 31, 1998, the government
released its final determination and definitions of the new IPS cost limits.
These changes in the reimbursement of home health agencies will result in a
significant impact on the profitability of these services. There is currently
proposed legislation that may alter the determination of the IPS cost limits.
IPS was implemented to position the home care industry for a Prospective
Payment System (PPS) which is to be implemented for cost reporting periods
beginning on or after October 1, 1999. Although PPS is not defined at this
time, it will take into consideration an appropriate unit of service and number
of visits within that unit, variations in the acuity of patients and the related
costs, and a general system design that provides for continued access to quality
services.
During the 1st quarter of 1998, the Company initiated a restructuring plan
which included cost reductions and productivity enhancements to position the
Company to be successful under the new IPS, as well as PPS. The Company reduced
operational cost, increased operational efficiencies and enhanced marketing
efforts, which should result in projected annualized cost savings of
approximately $5 million. The restructuring was substantially completed as of
June 30, 1998.
The implementation of IPS and the strategic decisions made by management
has resulted in a decrease to net revenues in the first and second quarters of
1998. The Company also expects to report losses in the third quarter of 1998
due to IPS.
As the home care industry faces changes in reimbursement structure,
Amedisys is committed to improve and streamline systems and take appropriate
actions to combat these changes and create a company focused on long-term
growth.
5. ACCRUED PAYROLL AND PAYROLL TAXES
The Company currently has an Employee Stock Ownership Plan ("ESOP")
relating to a subsidiary of the Company. During the second quarter of 1998, the
Company issued stock in the subsidiary valued at $705,000 to the ESOP.
4. PLACEMENT OF PREFERRED STOCK
In March, 1998, Amedisys completed a secondary phase of its private
placement of $.001 par value convertible preferred stock pursuant to Regulation
D of the Securities Act of 1933. The Company issued an additional 350,000
shares at $10 per share for gross proceeds of $3.5 million. The Company has
used the proceeds of this placement to fund synergistic acquisitions within the
South East and South Central regions of the U.S. in order to accelerate the
growth of its fully integrated network of outpatient health care services
including the Alternate Site Infusion Therapy division. These shares are
convertible into 756,757 shares of common stock which is equivalent to $4.625
per share.
5. ACQUISITIONS
In January 1998, the Company acquired all of the stock of Alliance Home
Health, Inc. ("Alliance"), a home health care business with locations throughout
Oklahoma, in exchange for $300,000 and 194,286 shares of common stock. Of the
194,286 shares of Company common stock issued to the former owners of Alliance,
122,857 shares were placed in escrow as consideration for certain contingent
liabilities which may be asserted against the former stockholder of Alliance to
the extent such claims exceed $500,000 (singularly and/or in aggregate). The
contingent liabilities include any material misstatement or omission in any
representation or breach of any warranty, covenant or agreement of Alliance or
its stockholder, any Medicare liabilities, any liability from lawsuits or
arbitration, any payment to be made by Alliance pursuant to a previous
acquisition, or any liability specifically addressed in the
7
<PAGE>
purchase document. The escrow period expires December 31, 2003. The majority
stockholder of Alliance entered into a three year employment agreement and two
year non-compete and non-solicitation agreement with the Company. The employment
agreement was terminated in March 1998. The non-compete and non-solicitation
agreement is for a period of two years after the termination of the employment
agreement. The non-compete and non-solicitation agreement provides that the
employee will not divert any business from the Company or compete in the
business area defined as the State of Oklahoma. This restricted activity is in
relation to home health agencies or infusion-related business. Additionally, the
non-compete and non-solicitation agreement provides that the employee will not
solicit employees or clients from the Company. A Form 8-K was filed on July 23,
1998 relating to this acquisition and includes audited financial statements for
Alliance Home Health, Inc. as well as proforma financial statements for the
Company and Alliance Home Health, Inc. consolidated.
In February 1998, the Company acquired all of the stock of PRN, Inc.
("PRN"), a home infusion pharmacy business located in San Antonio, Texas, in
exchange for $430,000 and the assumption of $71,000 in debt. The Company has
agreed to pay additional consideration of up to $150,000 should PRN have annual
net revenues of $625,000 for the next two years. This additional consideration
is to be paid quarterly for a period of two years, bearing interest at 9% from
the date of acquisition. The sellers, a key employee and his spouse, executed a
non-compete and non-solicitation agreement at the date of closing for a period
of two years within Bexar County Texas, which includes San Antonio, and any
counties contiguous thereto. The non-compete and non-solicitation agreement
provides that the sellers will not divert any business from the Company or
compete with the Company; as well as, not solicit any employees or clients of
the Company. This restricted activity is in relation to home infusion pharmacy
business. The Company has retained the right to offset certain indemnifiable
liabilities against the additional consideration.
In February 1998, the Company acquired all of the stock of Infusion Care
Solutions, Inc. ("ICS") a home health care and infusion business, based in Baton
Rouge, Louisiana, in exchange for aggregate consideration of $500,000, of which
$375,000 was payable in cash at closing and $125,000 was payable pursuant to a
two year promissory note. The note bears interest at prime plus 1% with 24
equal monthly payments. The sole stockholder executed a non-compete and non-
solicitation agreement at closing for a period of two years from the date of the
exchange. The business area is defined as the Parishes of East Baton Rouge,
Assumption, West Baton Rouge, Livingston, and Ascension in the State of
Louisiana. The non-compete and non-solicitation agreement provides that the
sole stockholder will not divert any business from the Company or compete with
the Company, as well as, not solicit any employees or clients of the Company.
The restricted business activity is in relation to any infusion or pharmacy
business unless such business is related to nursing home patients or assisted
living patients. The Company has retained the right to offset certain
indemnifiable liabilities against the sums payable pursuant to the promissory
note.
In February 1998, the Company acquired substantially all of the assets of
Precision Health Systems, L.L.C. ("PHS") a home health care and infusion
business, based in Baton Rouge, Louisiana, in exchange for aggregate
consideration of $1,000,000, of which $750,000 was payable in cash at closing
and $250,000 is payable pursuant to a two year promissory note. The note bears
interest at 9.5% with equal payments due monthly. The Company has retained the
right to offset certain indemnifiable liabilities against the sums payable
pursuant to the promissory note. The majority stockholder of PHS entered into a
two year non-competition and non-solicitation agreement and a two year
consulting agreement with the Company. The non-compete and non-solicitation
agreement provides that the sole stockholder will not divert any business from
the Company or compete with the Company; as well as, not solicit any employees
or clients of the Company. The business area is defined as the Parishes of East
Baton Rouge, Assumption, West Baton Rouge, Livingston, and Ascension in the
State of Louisiana. The restricted business is in relation to any infusion or
pharmacy business unless such business is related to nursing home patients or
assisted living patients. The consulting agreement is in the amount of $50,000
per year, payable in equal monthly increments. The majority stockholder is to
assist the Company in developing referral sources and retain current referral
sources.
8
<PAGE>
In March 1998, the Company acquired certain assets and no liabilities,
contingent or certain, prior to the closing date, of StaffCor Staffing Services,
L.L.C. (StaffCor) in exchange for $30,000 cash and $20,000 in additional
consideration payable quarterly over two years, without interest. This
additional consideration is to be paid prorata based on net income of StaffCor
without any adverse changes due to purchaser's corporate headquarters expense,
additional capital expenditures or materially increased operating expense. The
assets acquired were a minimal amount of furniture and fixtures, the right to
the StaffCor Staffing Service name, and contracts to provide medical staffing to
hospitals and other health care providers. The seller entered into a two year
non-competition and non-solicitation agreement with the Company. The non-
compete and non-solicitation agreement is for the business area of Oklahoma,
Grady and Logan Counties in the State of Oklahoma relative to any supplemental
staffing business. The non-compete and non-solicitation agreement provides that
the sole stockholder will not divert any business from the Company or compete
with the Company; as well as, not solicit any employees or clients of the
Company. StaffCor is a medical staffing business located in Oklahoma City,
Oklahoma.
In April 1998, the Company acquired all of the stock of Home Health of
Alexandria, Inc., d/b/a Cornerstone Home Health (Cornerstone), a closely held
entity, in exchange for $20,000 cash. With this acquisition, the Company will
have home health agencies serving all the major metropolitan areas in Louisiana.
A key employee and former stockholder executed an employment agreement with the
Company for a two year period; along with a non-compete and non-solicitation
agreement. The non-compete and non-solicitation agreement provides that the key
employee will not divert any business from the Company or compete with the
Company; as well as, not solicit any employees or clients of the Company. The
business area covered by the non-compete and non-solicitation agreement is for
the Parishes of Allen, Avoyelles, Caldwell, Catahoula, Concordia, Evangeline,
Grant, LaSalle, Natchitoches, Rapides, St. Landry, and Winn and is relative to
home health agencies. The agreement is for a two year period after the key
employee is no longer employed by the Company. Cornerstone is a state
licensed, Medicare certified, JCAHO accredited home health agency in Alexandria,
Louisiana.
In April 1998, the Company acquired all of the stock of Quality Home
Health Care, Inc. (Quality), of Stilwell, Oklahoma. In exchange, the Company
paid $80,000 and issued 4,897 shares of Company common stock worth $20,000. A
key employee and former stockholder executed an employment agreement for two
years in conjunction with a non-compete and non-solicitation agreement for a
period of two years after employment with the Company is terminated. The non-
compete and non-solicitation agreement provides that the key employee will not
divert any business from the Company or compete with the Company; as well as,
not solicit any employees or clients of the Company. The business area covered
by the non-compete and non-solicitation agreement is for the Counties of Adair,
Cherokee, Delaware, Haskell, Leflore, Mayes, McIntosh, Muskogee, Sequoyah, and
Wagoner in the State of Oklahoma and is relative to home health agencies.
Quality is a state licensed, Medicare certified home health agency with three
locations serving eastern Oklahoma.
In April 1998, the Company acquired certain assets of Precision Home
Health Care, Inc., (Precision) in exchange for $1,250,000; consisting of an
$800,000 note payable at 9.5% due July 1, 1998, a $400,000 note payable at 9.5%
payable monthly for a period of two years, and $50,000 in liabilities for
capital improvements. The $800,000 note payable has subsequently been extended
to October 1, 1998. The assets acquired were furniture and fixtures, inventory,
rights to use the Precision business name, current patients, and leasehold
interests. At closing the sole stockholder (who was also the majority
stockholder in the February 1998 ICS and PHS acquisitions) executed a non-
compete and non-solicitation agreement. The sole stockholder entered into a two
year non-competition and non-solicitation agreement which provides that the sole
stockholder will not divert any business from the Company or compete with the
Company; as well as, not solicit any employees or clients of the Company. The
business area is defined as the Parishes of East Baton Rogue, Assumption, West
Baton Rouge, Livingston, and Ascension in the State of Louisiana. The
restricted business activity is in relation to any Medicare or Medicaid home
health care business unless such business is related to nursing home patients or
assisted living patients. Additionally, the stockholder executed a consulting
agreement with the Company to provided services related to patient advocation,
introduce the Company to referral sources, and advise and assist the Company
concerning Medicare regulations. The consulting agreement is for a period of
two years in the amount of $50,000, payable monthly. Precision is a state
licensed, Medicare certified home health agency operating in the Baton Rouge,
Louisiana area.
Each of the above transactions was accounted for as a purchase.
9
<PAGE>
8. INCOME TAXES
The Company recorded a tax benefit of 34% of pre-tax loss at June 30, 1998,
as the Company anticipates carrying back taxable losses to previous years in
which the Company paid income taxes or generating taxable income in future
periods to offset the first and second quarter 1998 losses.
9. SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING ACTIVITY
The following unaudited table presents (in 000's) a summary of the
acquisitions completed during the first quarter of 1998 and a detail of the
acquisitions completed during the second quarter of 1998 as presented in the
supplemental schedule to the consolidated cash flow statement.
<TABLE>
<CAPTION>
Precision Quality Home
1st Quarter Home Home Health of
1998 Health, Health, Alexandria
Total Inc. Inc. Inc. Total
-------------- ----------- --------- ------------ -----------
<S> <C> <C> <C> <C> <C>
Supplemental schedule of non-cash investing activity:
Value of stock issued in exchange $ 874 $ 0 $ 20 $ 0 $ 894
Value of note payable issued in exchange 375 1,200 0 0 1,575
Cash acquired in exchange (123) (0) (132) (62) (317)
Working capital deficit acquired net of cash and cash
equivalents 3,272 0 306 (25) 3,553
Fair value of property, plant and equipment acquired (279) (102) 3 1 (385)
Fair value of other assets acquired (26) (0) 1 0 (27)
Long term debt assumed 2,998 0 2 69 3,069
Fair value of other liabilities assumed 54 0 0 0 54
------ ------- ----- ---- -------
Non cash portion of acquisitions 7,146 1,098 192 (20) 8,416
Cash payment for acquisition 1,905 0 80 20 2,005
------ ------- ----- ---- -------
Goodwill recorded in exchange $9,051 $ 1,098 $ 272 $ 0 $10,421
------ ------- ----- ---- -------
</TABLE>
10. NOTES PAYABLE
Notes payable consist primarily of borrowings under revolving bank lines of
credit of $7,500,000 and $750,000, bearing interest at bank prime plus 1.5% and
bank prime plus 1%, respectively. The lines of credit are collateralized by
80% of eligible receivables in staffing and outpatient surgery, 75% of eligible
receivables in home health care, and 80% of physician notes receivable.
Eligible receivables are defined principally as accounts that are aged less
than 90 days for staffing and outpatient surgery and 120 days for home health
care. At June 30, 1998, approximately $109,000 was available based on eligible
receivables under the combined lines of credit. The line of credit is subject to
certain covenants, including a monthly borrowing base, a debt service coverage
ratio, and a leverage ratio. At December 31, 1997, March 31, 1998, and June 30,
1998, the Company was in default on the debt service coverage ratio requirement
of 1.1 : 1.0 due to the losses incurred in these periods. This default was
waived by the bank through June 30, 1998.
11. OTHER CURRENT ASSETS
Included in Other Current Assets at June 30, 1998 is a deferred tax asset
of $2,279,000 resulting from the first and second quarter 1998 losses. The
Company anticipates carrying back taxable losses to previous years in which the
Company paid income taxes or generating taxable income in future periods to
offset the first and second quarter 1998 losses.
12. ACCOUNTS RECEIVABLE
Included in Accounts Receivable at June 30, 1998 is an accrual of
$2,600,000 for estimated Medicare reimbursement rate reductions for 1998 cost
reporting years related to the Home Health Nursing division.
10
<PAGE>
13. RECENT DEVELOPMENTS
On June 2, 1998, the Company signed a letter of intent to purchase a
portion of Columbia/HCA homecare operations subject to satisfactory completion
of due diligence and approval by the Board of Directors of both companies. The
homecare operations covered by the letter of intent are located in the states of
Alabama, Georgia, Louisiana, North Carolina, Oklahoma, and Tennessee and may
include up to 116 offices and 50 Medicare provider numbers. The Company is
currently conducting due diligence and negotiating with investment banks to
obtain financing for the purchase of these operations.
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS
The following discussion and analysis provides information which management
believes is relevant to an assessment and understanding of the Company's results
of operations and financial condition. This discussion should be read in
conjunction with the Consolidated Financial Statements appearing in Item 1.
GENERAL
Amedisys, Inc. (the "Company") is a leading multi-regional provider of
fully integrated alternate-site health care services. The Company's
alternative-site provider services division offers the following services:
infusion therapy; home health nursing services; and ambulatory surgery centers.
Its management services division includes staffing and professional services and
provider management services. The Company operates 55 offices within a network
of subsidiaries in the southern United States.
During the 1st quarter of 1998, the Company initiated a restructuring
plan which included cost reductions and productivity enhancements to position
the Company to be successful under the new IPS, as well as PPS (See note 4 to
financial statements). The Company reduced operational costs, increased
operational efficiencies and enhanced marketing efforts, which should result in
projected annualized cost savings of approximately $5 million. The restructuring
was substantially completed as of June 30, 1998.
The implementation of IPS and the strategic decisions made by management
has resulted in a decrease to net revenues in the 1st and 2nd quarters of
1998. The Company also expects to reports losses in the 3rd quarter of 1998
due to IPS while showing improved operating results.
The Company is developing a restructuring strategy which includes focusing
on the core business of being a home health care provider of nursing and
infusion therapy services. As a result, the Company is currently evaluating
opportunities to divest its non-core businesses, including supplemental
staffing, ambulatory surgery centers, and management services division.
RESULTS OF OPERATIONS
Revenues. Net revenues decreased 15% and 10% for the three and six months
ended June 30, 1998 as compared to the same periods in 1997. Home Health
Nursing division's net revenues decreased $2,067,000 or 34% for the three months
ended June 30, 1998 and $3,241,000 or 26% for the six months ended June 30,
1998, as compared to the same periods in 1997. This decrease was due to the
reductions in Medicare reimbursement rates as a result of the IPS and a
reduction in visits, offset by acquisitions made during the periods. Visits
for the three month period ended June 30 decreased from 98,916 in 1997 to 68,205
in 1998, inclusive of the acquisitions made in the second quarter of 1998. For
the six months period ended June 30, visits decreased from 202,309 in 1997 to
167,349 in 1998, inclusive of the acquisitions made in the first and second
quarters of 1998. Offsetting these comparative decreases in net revenues in the
Home Health Nursing division were revenues relating to the acquisition of Care
Medical & Mobility in August 1997 and the startup and acquisitions in the
Alternative Site Infusion Therapy division. Care Medical & Mobility recorded
net revenues of $730,000 and $1,133,000 for the three and six month periods
ending June 30, 1998, and Alternate Site Infusion Therapy recorded net revenues
of $877,000 and $1,410,000 for the three and six month periods ending June 30,
1998.
11
<PAGE>
Cost of Revenues. Cost of revenues decreased by 18% and 10% for the three
and six months ended June 30, 1998 as compared to the same periods in 1997. As
a percentage of the net revenues, cost of revenues decreased to 57% in the three
months ended June 30, 1998 from 58% for the three months ended June 30, 1997.
For the six month periods ended June 1997 and 1998, cost of revenues as a
percentage of net revenues have remained consistent at 59%.
General and Administrative Expenses ("G&A"). General and administrative
expenses increased by 55% and 66% for the three and six months ended June 30,
1998 as compared to the same periods in 1997. An increase of $2,153,000 and
$4,382,000 for the three and six months ended June 30, 1998 is directly
attributable to additional personnel and related expenses to support the startup
of the Alternate Site Infusion Therapy division as well as the Company's recent
acquisitions. Additionally, G&A expenses increased approximately $438,000 and
$1,188,000 from the three and six months ended June 30, 1997 to 1998 due to the
addition of experienced, senior management and increased resources for marketing
and managed care sales. These additions should enable the Company to achieve
its planned growth and position it to be a leader in the alternate-site
healthcare services market.
Provision for Estimated Income Taxes. The Company recorded a tax benefit
of 34% of pre-tax loss for the six months ended June 30, 1998.
Net Income (Loss). As a result of the reasons described above, the Company
had a net loss of ($1,903,000) for the three months ended June 30, 1998 compared
with net income of $373,000 for the three months ended June 30, 1997. For the
six month period ending June 30, 1998, the Company recorded a net loss of
($4,424,000) as compared to net income of $674,000 for the same period in 1997.
The company expects the loss to be significantly reduced during the latter half
of 1998 after all the cost reductions are implemented; however, there can be no
assurance the Company will be able to achieve the expected cost savings from its
restructuring efforts or will be able to reduce costs without negatively
impacting operations.
LIQUIDITY AND CAPITAL RESOURCES
Notes payable consist primarily of borrowings under revolving bank lines of
credit of $7,500,000 and $750,000, bearing interest at bank prime plus 1.5% and
bank prime plus 1%, respectively. The lines of credit are collateralized by 80%
of eligible receivables in staffing and outpatient surgery, 75% of eligible
receivables in home health care, and 80% of physician notes receivable.
Eligible receivables are defined principally as accounts that are aged less
than 90 days for staffing and outpatient surgery and 120 days for home health
care. At June 30, 1998, approximately $109,000 was available based on eligible
receivables under the combined lines of credit. The line of credit is subject
to certain covenants, including a monthly borrowing base, a debt service
coverage ratio, and a leverage ratio. At December 31, 1997, March 31, 1998, and
June 30,1998, the Company was in default on the debt service coverage ratio
requirement of 1.1 : 1.0 due to the losses incurred in these periods. This
default was waived by the bank through June 30, 1998.
The Company's operating activities used $3,620,000 during the first six
months of 1998, whereas such activities provided $242,000 in cash during the
first six months of 1997. This increase in cash used in operating activities
is primarily attributable to net losses partially offset by a decrease in
accounts receivable. Net cash used in investing activities increased to
$3,602,000 from $703,000 for the six months ending June 30, 1998 and 1997
respectively. Purchases of furniture, fixtures and equipment increased $871,000
in addition to $2,005,000 used to purchase several acquisitions. Net cash
provided by financing activities increased to $3,623,000 from $1,818,000 for the
six months ending June 30, 1998 and 1997, respectively. The change is primarily
due to a proceeds from a private placement of preferred stock.
At June 30, 1998, the Company had negative working capital of ($3,804,000)
and stockholder's equity of $8,763,000. The Company's ratio of total
liabilities to equity at June 30, 1998 was 2.2 to 1.0. The Company's sources of
external and internal financing are limited. The Company will need to obtain
additional financing in order to meet future capital requirements or complete
further acquisitions.
12
<PAGE>
ACCOUNTING FOR DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES
In June 1998, the Financial Accounting Standards Board issued Statement of
Financial Accounting Standards No. 133 ("SFAS 133"), "Accounting for Derivative
Instruments and Hedging Activities". The Statement establishes accounting and
reporting standards requiring that every derivative instrument (including
certain derivative instruments embedded in other contracts) be recorded in the
balance sheet as either an asset or liability measured at its fair value. The
Statement requires that changes in the derivative's fair value be recognized
currently in earnings unless specific hedge accounting criteria are met.
Special accounting for qualifying hedges allows a derivative's gains and losses
to offset related results on the hedged item in the income statement, and
requires that a company must formally document, designate, and assess the
effectiveness of transactions that receive hedge accounting. SFAS 133 is
effective for fiscal years beginning after June 15, 1999 and must be applied to
instruments issued, acquired, or substantively modified after December 31, 1997.
The Company does not expect the adoption of the accounting pronouncement to have
a material effect on its financial position or results of operations.
YEAR 2000 COMPLIANCE ISSUES
The Company is currently evaluating its information system for the Year
2000 compliance. The Company does not anticipate any material disruption in its
operations resulting from any failure by the Company to achieve compliance. At
present, the Company does not have, but expects to solicit, information
concerning the Year 2000 compliance status of its suppliers, customers, and
payors. In the event that any of the Company's significant suppliers,
customers, or payors does not successfully and timely achieve Year 2000
compliance, the Company's business or operations could be adversely affected.
FORWARD LOOKING STATEMENTS
When included in the Quarterly Report on Form 10-Q or in documents
incorporated herein by reference, the words "expects", "intends", "anticipates",
"believes", "estimates", and analogous expressions are intended to identify
forward-looking statements. Such statements inherently are subject to a variety
of risks and uncertainties that could cause actual results to differ materially
from those projected. Such risk and uncertainties include, among others,
general economic and business conditions, current cash flows and operating
deficits, debt services needs, adverse changes in federal and state laws
relating to the health care industry, competition, regulatory initiatives and
compliance with governmental regulations, customer preferences and various other
matters, many of which are beyond the Company's control. Theses forward-looking
statements speak only as of the date of the Quarterly Report on Form 10-Q. The
Company expressly disclaims any obligation or undertaking to release publicly
any updates or any changes in the Company's expectations with regard thereto or
any changes in events, conditions or circumstances on which any statement is
based.
PART II. OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
None
ITEM 2. CHANGES IN SECURITIES
During the second quarter of 1998, the Company's Nasdaq trading symbol was
changed from "AMED" to "AMEDE". This trading symbol change resulted from the
Company's lack of compliance with Nasdaq criteria pertaining to net tangible
assets as a result of acquisitions and operating losses in the first and second
quarters of 1998.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
At June 30, 1998, the Company was in default on the $7,500,000 revolving
bank line of credit. The line of credit is collateralized by accounts
receivable and is subject to certain covenants, including a monthly borrowing
base, a debt service coverage ratio, and a leverage ratio. The Company was in
default on the debt service coverage ratio requirement of 1.1 : 1.0 due to the
losses incurred in these periods. This default was waived by the bank.
13
<PAGE>
ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
None
ITEM 5. OTHER INFORMATION
None
ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K
(a) Exhibits
Exhibit
No. Identification of Exhibit
- -------- -------------------------
2.1(1) --- Stock Purchase Agreement by and among Amedisys Specialized
Medical Services, Inc., Quality Home Health Care, Inc., Frances
Unger, and James Unger dated May 1, 1998.
2.2(1) --- Asset Purchase Agreement by and among Amedisys Specialized
Medical Services, Inc., and Precision Home Health Care, Inc.
dated May 1, 1998.
2.3(1) --- Promissory note in the amount of $800,000 to Precision Home
Health Care, Inc. in connection with the purchase of the company.
2.4(1) --- Promissory note in the amount of $400,000 to Precision Home
Health Care, Inc. in connection with the purchase of the company.
27.1 --- Financial Data Schedule
(1) Previously filed as an exhibit to the Company's Quarterly Report on
Form 10-Q/A for the period ended June 30, 1998 filed October 5, 1998
and incorporated herein by reference.
(b) Report on Form 8-K
No reports on form 8-K were filed during the second quarter of 1998.
14
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
AMEDISYS, INC.
By:/s/ MITCHEL G. MOREL
---------------------------------
Mitchel G. Morel
Chief Financial Officer, Principal
Financial and Accounting Officer
DATE: October 23, 1998
15
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> DEC-31-1998
<PERIOD-START> JAN-01-1998
<PERIOD-END> JUN-30-1998
<CASH> 471,000
<SECURITIES> 0
<RECEIVABLES> 7,249,000
<ALLOWANCES> 2,957,000
<INVENTORY> 1,054,000
<CURRENT-ASSETS> 9,658,000
<PP&E> 9,959,000
<DEPRECIATION> 3,903,000
<TOTAL-ASSETS> 28,312,000
<CURRENT-LIABILITIES> 13,462,000
<BONDS> 4,948,000
0
1,000
<COMMON> 3,000
<OTHER-SE> 8,759,000
<TOTAL-LIABILITY-AND-EQUITY> 28,312,000
<SALES> 0
<TOTAL-REVENUES> 24,475,000
<CGS> 0
<TOTAL-COSTS> 14,319,000
<OTHER-EXPENSES> 16,072,000
<LOSS-PROVISION> 415,000
<INTEREST-EXPENSE> 418,000
<INCOME-PRETAX> (6,703,000)
<INCOME-TAX> (2,279,000)
<INCOME-CONTINUING> (4,424,000)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (4,424,000)
<EPS-PRIMARY> (1.45)
<EPS-DILUTED> (1.45)
</TABLE>
